342 filings
8-K
ARIA
ARIAD Pharmaceuticals Inc
16 Feb 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
6 Feb 17
ARIAD Announces Submission of Marketing Authorization Application for Brigatinib to the European Medicines Agency
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
10 Jan 17
Entry into a Material Definitive Agreement
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
8 Dec 16
Other Events
12:00am
8-K
ARIA
ARIAD Pharmaceuticals Inc
7 Dec 16
Departure of Directors or Certain Officers
12:00am
8-K
ldcp40vt0ed1ztwfdfs
30 Nov 16
Other Events
12:00am
8-K
rspwgq01n 61obu
18 Nov 16
ARIAD Announces Data Presentations at the World Conference on Lung Cancer
12:00am
8-K
2s2zs cpmc
7 Nov 16
ARIAD Reports Third Quarter 2016 Financial Results
12:00am
8-K
u8ue3g6wya rt
31 Oct 16
ARIAD Announces U.S. Food and Drug Administration Acceptance of NDA Filing for Brigatinib
12:00am
8-K
xrawdh0fypsi700 yu2g
29 Sep 16
ARIAD Announces Regulatory Approval for Iclusig® (ponatinib) in Japan
12:00am
8-K
787oyn 7bt2
30 Aug 16
ARIAD Completes Rolling Submission of New Drug Application for Brigatinib to the U.S. Food and Drug Administration
12:00am
8-K
wbt5x36
28 Jul 16
ARIAD Reports Second Quarter and First Half 2016 Financial Results
12:00am
8-K
q1wfi9
22 Jul 16
Submission of Matters to a Vote of Security Holders
12:00am
8-K
8gizq96fpeid rpq8nd
7 Jun 16
Other Events
12:00am
8-K
640oowmezd9vutg
2 Jun 16
Entry into a Material Definitive Agreement
12:00am
8-K
4vi7pl
26 May 16
Ariad Announces Appointment of Jennifer L. Herron
12:00am
8-K
w9ahu 72sut57jnp5xy
20 May 16
Departure of Directors or Certain Officers
12:00am
8-K
4myvvvma7
19 May 16
ARIAD Announces Data Presentations at the 2016 ASCO Annual Meeting
12:00am
8-K
yj39c8l lq2m4ab9o2t
10 May 16
ARIAD Reports First Quarter 2016 Financial Results and Progress on Strategic Review
12:00am
8-K
0cmf 5kc7ld4zah4v2eg
9 May 16
Incyte and Ariad Announce Agreement for Incyte to Acquire
12:00am